Toyoaki Uchida

Summary

Country: Japan

Publications

  1. ncbi High-intensity focused ultrasound therapy for prostate cancer
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    Int J Urol 19:187-201. 2012
  2. ncbi High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Tokai University, Isehara, Kanagawa, Japan
    BJU Int 107:378-82. 2011
  3. ncbi Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Japan
    Int J Urol 13:228-33. 2006
  4. ncbi Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    Int J Urol 16:881-6. 2009
  5. ncbi Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study
    Sunao Shoji
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    Int J Urol 17:715-9. 2010
  6. ncbi Treatment of localized prostate cancer using high-intensity focused ultrasound
    Toyoaki Uchida
    University of Tokai Hachioji Hospital, Hachioji, Japan
    BJU Int 97:56-61. 2006
  7. ncbi Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy
    Akiko Murota-Kawano
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    BJU Int 105:1642-5. 2010
  8. ncbi To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Tokyo, Japan
    BJU Int 98:537-9. 2006
  9. ncbi Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor
    Sunao Shoji
    Department of Urology, Tokai University School of Medicine, Isehara City, Kanagawa, Japan
    Eur Urol 55:441-9. 2009
  10. ncbi [Renal infarction with renal abscess onset due to infective endocarditis: a case report]
    Sunao Shoji
    Department of Urology, Tokai University, School of Medicine, Hachioji Hospital
    Hinyokika Kiyo 54:221-3. 2008

Collaborators

Detail Information

Publications19

  1. ncbi High-intensity focused ultrasound therapy for prostate cancer
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    Int J Urol 19:187-201. 2012
    ..High-intensity focused ultrasound is likely to play a significant role in the future of oncology practice...
  2. ncbi High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Tokai University, Isehara, Kanagawa, Japan
    BJU Int 107:378-82. 2011
    ..To investigate the use of high-intensity focused ultrasound (HIFU) as a salvage therapy in patients with recurrence of localized prostate cancer after external beam radiation (EBRT), brachytherapy, or proton therapy...
  3. ncbi Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Japan
    Int J Urol 13:228-33. 2006
    ..We evaluated biochemical disease-free survival rates, predictors of clinical outcome and morbidity in patients with localized prostate cancer treated with HIFU...
  4. ncbi Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    Int J Urol 16:881-6. 2009
    ..To report on the long-term results of high-intensity focused ultrasound in the treatment of localized prostate cancer...
  5. ncbi Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study
    Sunao Shoji
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    Int J Urol 17:715-9. 2010
    ..To report our health-related quality of life (QOL) and functional outcomes following high-intensity focused ultrasound (HIFU) for localized prostate cancer...
  6. ncbi Treatment of localized prostate cancer using high-intensity focused ultrasound
    Toyoaki Uchida
    University of Tokai Hachioji Hospital, Hachioji, Japan
    BJU Int 97:56-61. 2006
    ....
  7. ncbi Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy
    Akiko Murota-Kawano
    Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan
    BJU Int 105:1642-5. 2010
    ..To present experience in high-intensity focused ultrasound (HIFU) used as a salvage therapy for biopsy-confirmed local recurrence at the vesico-urethral anastomosis after radical prostatectomy (RP)...
  8. ncbi To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Tokyo, Japan
    BJU Int 98:537-9. 2006
    ....
  9. ncbi Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor
    Sunao Shoji
    Department of Urology, Tokai University School of Medicine, Isehara City, Kanagawa, Japan
    Eur Urol 55:441-9. 2009
    ..Metastin, the final peptide of the KiSS-1 gene, has been proposed to suppress cell motility...
  10. ncbi [Renal infarction with renal abscess onset due to infective endocarditis: a case report]
    Sunao Shoji
    Department of Urology, Tokai University, School of Medicine, Hachioji Hospital
    Hinyokika Kiyo 54:221-3. 2008
    ..The renal diseases associated with infective endocarditis were found to be diverse and we concluded that it is important to understand the conditions of the disease correctly for appropriate treatment...
  11. ncbi [Retroperitoneal mixed-type liposarcoma detected by health examination]
    Sunao Shoji
    Department of Urology, Tokai University Hachioji Hospital
    Hinyokika Kiyo 55:555-7. 2009
    ..The resected tissue was a pale yellow solid and white mucous mass, weighing 1,100 g. Histopathological examination of excised tumors revealed mixed-type liposarcoma (well-differentiated and myxoid types). He received no adjuvant therapy...
  12. ncbi Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report
    Toyoaki Uchida
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    Urology 59:394-8; discussion 398-9. 2002
    ..Transrectal HIFU may be a useful option for patients with localized prostate cancer. Its long-term efficacy will be determined by additional follow-up and a Phase II trial...
  13. ncbi Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma
    Toyoaki Uchida
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan
    Urology 59:615-20. 2002
    ..CONCLUSIONS: Our results indicate that stage, p53 expression, mdm2 expression, and coexpression of p53/mdm2 are useful to predict the clinical outcome in patients with renal cell carcinoma...
  14. ncbi The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital, Tokyo, Japan
    BJU Int 98:770-2. 2006
    ..119). CONCLUSION: In this unrandomized comparison between neoadjuvant or no AS before HIFU for men with presumed organ-confined prostate cancer, there appeared to be little if any benefit associated with the previous administration of AS...
  15. ncbi [High-intensity focused ultrasound for localized prostate cancer]
    Toyoaki Uchida
    Department of Urology, Tokai University Hachioji Hospital
    Nippon Rinsho 63:345-9. 2005
    ..01-30.0 ng/ml and more than 30.01 ng/ml were 88%, 67%, 34% and 13% (log rank test, p < 0.0001), respectively. HIFU therapy appears to be a safe, efficacious and minimally invasive therapy for patients with localized prostate cancer...
  16. ncbi Efficacy of short-term androgen deprivation with high-intensity focused ultrasound in the treatment of prostate cancer in Japan
    Makoto Sumitomo
    Department of Urology, National Defense Medical College, Tokorozawa, Japan
    Urology 72:1335-40. 2008
    ..To determine whether combining short-term neoadjuvant androgen deprivation therapy (NADT) with high-intensity focused ultrasound (HIFU) had a significant benefit in a large population of men with nonmetastatic prostate cancer (CaP)...
  17. ncbi Kidney disease quality of life of Japanese dialysis patients who desire administration of sildenafil and the treatment of erectile dysfunction using sildenafil
    Toru Hyodo
    Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan
    Ther Apher Dial 8:340-6. 2004
    ..Diabetic status is thought to be a negative factor for the response of sildenafil treatment in dialysis patients...
  18. ncbi [Review of transurethral endoscopic surgery]
    Sunao Shoji
    Department of Urology, Tokai University Hachioji Hospital
    Nihon Rinsho 68:1320-3. 2010
    ..But, a long follow-up are necessary for evaluation of these novel treatments. We reviewed the literature of transurethral endoscopic surgery of BPH, superficial bladder cancer, urinary calculus and vesicoureteral reflex...
  19. ncbi Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study
    Toyoaki Uchida
    The Department of Urology, Tokai University Hachioji Hospital
    Hinyokika Kiyo 51:651-8. 2005
    ..HIFU therapy appears to be minimally invasive, efficacious and safe for patients with localized prostate cancer with pretreatment PSA levels less than 20 ng/ml...